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Abstract
RNA interference (RNAi) utilizes small interfering RNAs (siRNAs) to direct silencing of specific genes through transcriptional
and post-transcriptional mechanisms. The siRNA guides can originate from exogenous (exo–RNAi) or natural endogenous
(endo–RNAi) sources of double-stranded RNA (dsRNA). In Caenorhabditis elegans, inactivation of genes that function in the
endo–RNAi pathway can result in enhanced silencing of genes targeted by siRNAs from exogenous sources, indicating
cross-regulation between the pathways. Here we show that members of another small RNA pathway, the mir-35-41 cluster
of microRNAs (miRNAs) can regulate RNAi. In worms lacking miR-35-41, there is reduced expression of lin-35/Rb, the C.
elegans homolog of the tumor suppressor Retinoblastoma gene, previously shown to regulate RNAi responsiveness.
Genome-wide microarray analyses show that targets of endo–siRNAs are up-regulated in mir-35-41 mutants, a phenotype
also displayed by lin-35/Rb mutants. Furthermore, overexpression of lin-35/Rb specifically rescues the RNAi hypersensitivity
of mir-35-41 mutants. Although the mir-35-41 miRNAs appear to be exclusively expressed in germline and embryos, their
effect on RNAi sensitivity is transmitted to multiple tissues and stages of development. Additionally, we demonstrate that
maternal contribution of miR-35-41 or lin-35/Rb is sufficient to reduce RNAi effectiveness in progeny worms. Our results
reveal that miRNAs can broadly regulate other small RNA pathways and, thus, have far reaching effects on gene expression
beyond directly targeting specific mRNAs.
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Introduction
The ability of double stranded RNA (dsRNA) to induce
silencing of specific genes was discovered in the nematode
Caenorhabditis elegans and dubbed RNA interference (RNAi) [1].
RNAi was subsequently identified in many organisms, including
mammals, providing a powerful experimental tool for inactivating
specific genes [2,3]. In worms, RNAi can be initiated by long
dsRNAs from exogenous sources, such as injected or ingested
bacterially produced dsRNA [1,4]. Cellular factors process the
dsRNAs into small interfering RNAs (exo–siRNAs) of ,21
nucleotides long, which target complementary mRNAs for
degradation [5]. Exo–siRNAs form complexes with Argonaute
proteins that mediate target mRNA cleavage or degradation
through other mechanisms [6]. Recently, a nuclear RNAi pathway
was discovered in worms where the Argonaute NRDE-3 silences
target genes through a co-transcriptional mechanism of silencing
[7,8].
Comparable to exo–RNAi, endogenous dsRNAs can enter
processing pathways that produce endo–siRNAs that silence target
genes through base-pairing interactions [6,9]. Endo–siRNAs have
been identified by small RNA cloning in C. elegans, Drosophila and
mouse and are predicted to target thousands of endogenous
genes, particularly mRNAs present in germline and embryos
[10,11,12,13,14,15]. In C. elegans, both the exo- and endo–siRNA
pathways require the endoribonuclease enzyme Dicer (DCR-1) to
process the initiating dsRNAs into ,21 nt siRNAs, but distinct
Argonaute proteins usually bind the different types of siRNAs to
mediate gene silencing [16,17]. For example the Argonaute RDE-
1 is required for RNAi initiated by exogenous but not endogenous
dsRNAs [17].
In nematodes and plants, RNAi-mediated silencing can be
amplified through the production of secondary siRNAs by RNA
dependent RNA polymerases (RdRPs). In C. elegans, loss of the
RdRP RRF-3 results in greatly reduced levels of endo–siRNAs
and an enhanced response to exogenous dsRNA [18,19]. Likewise,
the exonuclease ERI-1 is required for the accumulation of
some endo–siRNAs and worms with mutations in eri-1 display
hypersensitivity to exo–siRNAs [18,20]. Another class of mutants
with enhanced RNAi is represented by lin-35/Rb, which encodes
the worm homolog of the Retinoblastoma tumor suppressor, and
includes other genes in the lin-35/Rb pathway such as lin-15, dpl-1
(mammalian DP), and hpl-2 (mammalian HP1) [21,22,23]. The
molecular mechanism by which lin-35/Rb negatively regulates the
RNAi pathway remains to be fully understood. Worms with
mutations in lin-35/Rb have up-regulated levels of mRNAs
corresponding to cloned endo–siRNAs, suggesting decreased levels
or function of endo–siRNAs in these mutants [24]. Reduced
endo–RNAi activity may free limiting factors for the exo–RNAi
pathway. Furthermore, some of the up-regulated genes in lin-35/
Rb mutants encode Argonaute proteins that might also contribute
to enhanced exo–RNAi [24]. Additionally, lin-35/Rb mutants
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tissues [23]. This expression pattern is predicted to enhance RNAi
sensitivity by providing factors normally utilized in the germline
for silencing pathways [23].
MicroRNAs (miRNAs) represent another class of small RNAs
that derive from endogenously expressed transcripts [25].
Typically, miRNAs are transcribed as long primary transcripts
containing hairpin structures that are released by Drosha cleavage.
The resulting precursor undergoes processing by Dicer to produce
the mature ,22 nt miRNA, which forms a complex with
Argonaute proteins. While mammalian miRNAs seem to distrib-
ute evenly among the four Argonaute proteins, worm and fly
miRNAs mostly associate with specific Argonautes [6]. For
example, Argonaute Like Genes 1 and 2 (ALG-1/2) bind worm
miRNAs, but not exo- or endo–siRNAs [26]. In contrast to exo
and endo–siRNAs, animal miRNAs pair with imperfect sequence
complementarity to their target mRNAs, causing target degrada-
tion and translational repression [27]. The common factor for
most small RNA pathways is Dicer. Loss of Dicer activity in worm
or mammalian cells results in defective RNAi and severely reduced
levels of most miRNAs and endo–siRNAs [16,18,28,29,30].
However, mutations in other genes required for endo- or exo–
RNAi seem to have little effect on the miRNA pathway in C.
elegans [16,18].
In an effort to understand the function of specific miRNAs, a
large collection of deletion mutants was generated in C. elegans
[31]. While most individual mutants displayed no obvious
phenotypes, simultaneous deletion of multiple family members
(miRNAs with identical sequences at positions 2–7) often resulted
in developmental defects and lethality [32,33]. For example, the
miR-35-41 miRNAs are clustered within ,800 nt of a common
transcript and share a high degree of sequence homology [34].
Deletion of this miRNA cluster results in defective germ and
intestinal cell proliferation and temperature sensitive embryonic
lethality [32,35]. While the genes regulated by miR-35-41 that are
responsible for these phenotypes are yet to be determined, several
direct targets of these miRNAs were recently validated in
embryonic extracts [36]. Although the miR-35-41 miRNAs have
only been found in worms and planaria [34,37], poorly conserved
miRNA clusters have also been observed to be highly expressed
and function in early development in other species, including
Drosophila, mouse and humans [38,39,40].
Here we show that the miR-35-41 miRNAs regulate other small
RNA pathways in C. elegans. Deletion of the miRNA cluster results
in worms with enhanced RNAi sensitivity in multiple develop-
mental stages and tissues. This effect is likely related to decreased
endo–RNAi activity in mir-35-41 mutants, as they also exhibit up-
regulation of many endo–siRNA targets. We found that the miR-
35-41 miRNAs negatively regulate the exo–RNAi pathway
through lin-35/Rb and that this function can be supplied
maternally to the progeny. These results point to a new level of
cross-regulation between small RNA pathways, whereby the
expression of specific miRNAs can impact the efficiency of RNAi
mediated by exo– and endo–siRNAs.
Results
Enhanced RNAi in mir-35-41 mutants
In C. elegans the mir-35-41 miRNAs are required for embryonic
viability and proliferation of certain cell types, but the targets
relevant for these phenotypes have not yet been established
[31,32,35]. In the mir-35-41(gk262) and mir-35-41(nDf50) strains
all seven members of the miRNA cluster are deleted, resulting in
temperature sensitive embryonic lethality (Figure S1) [31,32].
While using RNAi to identify factors that genetically interact with
mir-35-41(gk262), we discovered that this strain exhibits enhanced
sensitivity to RNAi. In agreement with previous studies [1,4], wild
type worms fed bacteria expressing double stranded RNA
targeting the muscle gene unc-22 resulted in a high penetrance
of worms with the twitching phenotype, while only 2% resembled
the null unc-22 loss-of-function phenotype of paralysis (Figure 1A
and Table 1) [41]. In contrast, the majority (83%) of mir-35-
41(gk262) worms were paralyzed by unc-22(RNAi) (Figure 1A and
Table 1). This same treatment produced paralysis in about 20% of
the established RNAi hypersensitive strain, rrf-3(pk1426) (Table 1),
consistent with previous studies [19,20]. We confirmed that the
enhanced RNAi phenotype of mir-35-41(gk262) was due to loss of
the miRNA gene instead of the overlapping anti-sense Y62F5A.9
protein-coding gene. A transgene encoding only the mir-35-41
locus rescued the hypersensitivity of this strain to unc-22(RNAi)
(Figure 1A) and supported miRNA expression in mir-35-41(gk262)
worms (Figure 1B).
Loss of mir-35-41 results in enhanced RNAi in multiple tissues
and stages of development. We observed that RNAi knockdown of
lin-1 (hypodermal), sqt-1 (hypodermal), unc-86 (neuronal), pos-1
(germline) and sex-1 (embryonic) resulted in enhanced phenotypes
in mir-35-41(gk262) relative to wild type worms (Table 1).
Furthermore, the effects were similar or stronger in mir-35-
41(gk262) compared to the RNAi hypersensitive rrf-3 mutants.
These results indicate that expression of the miR-35-41 miRNAs
negatively impacts the efficiency of exo–RNAi in C. elegans.
To determine if the enhanced RNAi phenotype of mir-35-
41(gk262) was dependent on core exo–RNAi factors, we crossed
this strain to mutants in the RNAi pathway. Upon unc-22(RNAi)
treatment, the single mutants defective in RNAi (rde-1, rde-4 and
rrf-1) showed no phenotypic response, as expected (Table 2)
[42,43,44]. Likewise, addition of mutations in rde-1, rde-4 or rrf-1
rendered mir-35-41(gk262) mutants completely RNAi defective
(Table 2). These data show that mir-35-41(gk262) mutants require
Author Summary
RNA interference (RNAi) has become a widely used
approach for silencing genes of interest. This tool is
possible because endogenous RNA silencing pathways
exist broadly across organisms, including humans, worms,
and plants. The general RNAi pathway utilizes small ,21-
nucleotide RNAs to target specific protein-coding genes
through base-pairing interactions. Since RNAs from
exogenous sources require some of the same factors as
endogenous small RNAs to silence gene expression, there
can be competition between the pathways. Thus, pertur-
bations in the endogenous RNAi pathway can result in
enhanced silencing efficiency by exogenous small RNAs.
MicroRNAs (miRNAs) comprise another endogenous small
RNA pathway, but their biogenesis and mechanism of
gene silencing are distinct in many ways from RNAi
pathways. Here we show that a family of miRNAs regulates
the effectiveness of RNAi in Caenorhabditis elegans. Loss of
mir-35-41 results in enhanced RNAi by exogenous RNAs
and reduced silencing of endogenous RNAi targets. The
embryonic miR-35-41 miRNAs regulate the sensitivity
to RNAi through lin-35/Rb, a homolog of the human
Retinoblastoma tumor suppressor gene previously shown
to regulate RNAi effectiveness in C. elegans. Additionally,
we show that this sensitivity can be passed on to the next
generation of worms, demonstrating a far-reaching effect
of the miR-35-41 miRNAs on gene regulation by other
small RNA pathways.
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be expected, there is precedence for an RNAi hypersensitive strain
(lin-15B(n744)) being independent of rrf-1 activity [23].
The response of mir-35-41(gk262) to unc-22(RNAi) is compara-
ble to that of the exceptionally RNAi hypersensitive strain lin-
35(n745), which carries a putative null mutation [21,22,23,45].
About 20–30% of the population of the enhanced RNAi strains rrf-
3(pk1426), eri-1(mg366) and ergo-1(tm1860) exhibited paralysis in
response to unc-22(RNAi) (Table 3). In comparison, over 80% of
the mir-35-41(gk262) and lin-35(n745) strains were paralyzed by
this RNAi treatment (Table 3). The rrf-3, eri-1 and ergo-1 genes are
part of the endogenous RNAi pathway in C. elegans and loss of
these genes results in decreased levels of endo–siRNAs
[16,17,18,46]. Diminished activity of the endo–RNAi pathway is
one explanation for enhanced RNAi sensitivity to dsRNA from
exogenous sources. The Argonaute protein NRDE-3 serves as a
sensor for endo–siRNAs, as nuclear localization of this protein is
dependent on the presence of siRNAs [8]. In contrast to wild type
worms that express endo–siRNAs, GFP::NRDE-3 was mostly
cytoplasmic in the seam cells of eri-1(mg366) worms, which are
defective in endo–siRNA accumulation (Figure 2A) [8,16,18]. As
in wild type, localization of GFP::NRDE-3 was nuclear in the mir-
Figure 1. Deletion of the mir-35-41 miRNA cluster results in RNAi hypersensitivity. (A) L4 stage wild type, mir-35-41(gk262) and mir-35-
41(gk262); apEx160 [mir-35-41] strains were grown on bacteria expressing unc-22 dsRNA (open columns) or the empty RNAi vector L4440 (black
columns). The percentages of paralyzed worms after 28 h of exposure to RNAi conditions are graphed as the mean and standard deviation from three
independent experiments. (B) PAGE Northern blot analysis of RNA from wild type, mir-35-41(gk262) and mir-35-41(gk262); apEx160 [mir-35-41]
embryos shows restored expression of precursor and mature mir-35 miRNA in the transgenic strain. 5.8S rRNA levels are shown as loading controls.
doi:10.1371/journal.pgen.1002536.g001
Table 1. The mir-35-41(gk262) mutant worms show enhanced RNAi in multiple tissues and stages of development.
Gene RNAi phenotype Worm strains Tissue
wt rrf-3(pk1426) mir-35-41(gk262)
unc-22 % Prl* 262 (629) 1765 (594) 83614(651) muscle
lin-1 % Muv{ 160 (867) 5467 (931) 6968 (580) hypodermal
sqt-1 % Rol{ 761 (120) 8064 (243) 8466 (220) hypodermal
unc-86 % Prl* 1463 (173) 3666 (354) 8062 (291) neuronal
pos-1 %E m b {{ 1064 (248) 10062 (456) 10061 (513) germline
sex-1 %E m b {{ 36611 (298) 9861 (522) 10060 (832) embryonic
Worm strains of the indicated genotype were grown on bacteria expressing dsRNA against the indicated genes at 20uC. RNAi phenotype results are mean 6 standard
deviation (average of 3 independent experiments). Numbers in parentheses represent the total number of adult worms or embryos scored.
*L4 staged worms were transferred to RNAi and the percentage of paralyzed (%Prl) adult worms was scored 28 hours later.
{L1 staged worms were plated on RNAi and the percentage of adult worms showing multivulva (%Muv) or roller (% Rol) phenotypes was scored.
{{L4 staged worms were transferred to RNAi, allowed to lay embryos and adult worms were removed 28 hours later. Percent embryonic lethal (%Emb) was calculated
as the number of embryos that did not hatch.
doi:10.1371/journal.pgen.1002536.t001
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tionally, the hypersensitivity of mir-35-41 mutants continued in the
absence of nrde-3 activity (Figure 2B). These results show that in
mir-35-41 mutants sufficient endo–siRNAs are present to target
NRDE-3 to the nucleus and the enhanced RNAi phenotype of
these mutants does not require NRDE-3 activity.
Up-regulation of endogenous siRNA targets in mir-35-41
mutants
To gain insight into the role of the mir-35-41 miRNAs in
regulating the exo–RNAi pathway, we performed microarray
analysis of gene expression in WT versus mir-35-41(gk262)
embryos. We chose statistically significant changes in gene
expression of at least 1.5-fold differences between the triplicate
sample averages (p value#0.005 (two-sample t-test)) (Table S1). Of
the 550 up-regulated genes in mir-35-41(gk262), only a small
fraction (4%) were predicted miR-35 targets based on a list of 606
genes from four different algorithms (Targetscan, PicTar, RNA22
and MiRWIP). Furthermore, obvious genes that might explain the
heightened RNAi sensitivity of mir-35-41(gk262) were not mis-
regulated at the mRNA level. Comparing the microarray results to
a list of 6,469 endo–siRNA targets obtained from four indepen-
dent studies revealed significant enrichment of endo–siRNA
targets in the up-regulated genes (37%, p value 1.3e-05 two tailed
exact Fisher’s significance test) (Table S1) [11,13,18,47]. In
contrast, endo–siRNA targets were under-represented in the list
of genes down-regulated in mir-35-41(gk262) (13% p value 2.2e-16
exact Fisher’s significance test) (Table S1). Differential expression
of the established endo–siRNA target E01G4.5 was confirmed by
RT-qPCR (Figure 3). Similar to the previously reported effect of
eri-1 on this gene, both the spliced and unspliced forms of E01G4.5
were up-regulated in mir-35-41 mutants (Figure 3) [8].
Decreased LIN-35/Rb contributes to the RNAi
hypersensitivity of mir-35-41 mutants
The mir-35-41 and lin-35/Rb mutant strains both show strongly
enhanced RNAi and up-regulation of endo–siRNA targets. Also
both strains resemble WT for NRDE-3 localization, which is
dependent on siRNAs for nuclear residence (Table 3, Table S1,
Figure 2) [21,22,23,24]. These similarities led us to investigate if
the mir-35-41 and lin-35/Rb genes might regulate each other.
Although lin-35/Rb mRNA levels were not significantly different,
protein levels of this gene were reduced to about 20% in mir-35-
41(gk262) relative to wild type worm embryos (Figure 4A and 4B),
suggesting that mir-35-41 positively regulates the accumulation of
LIN-35 protein. In contrast, mir-35 miRNA levels were unaltered
in lin-35(n745) mutant embryos (Figure 4C). The decreased levels
of LIN-35 protein could be responsible for the RNAi hypersen-
sitivity of mir-35-41 mutants. To test this possibility, we crossed an
extrachromosomal array expressing lin-35 into mir-35-41(gk262).
Worms carrying the array, Ex[lin-35(+); sur-5::GFP], are distin-
guished by GFP expression [48]. In the mir-35-41(gk262) worms
with extra copies of lin-35 provided by the array (GFP+), the
hypersensitivity to unc-22(RNAi) was rescued with the majority of
worms showing the twitching instead of paralysis phenotype
(Figure 4D). The non-GFP (GFP2) siblings were comparable to
the original mir-35-41(gk262) strain for sensitivity to unc-22(RNAi)
(Figure 4D). Other GFP transgenes that lack lin-35 did not affect
the RNAi hypersensitivity of mir-35 mutants, consistent with the
idea that lin-35 is required for the rescue (Figure 4D). The extra
copies of lin-35 also reduced the RNAi hypersensitivity of lin-
35(n745) genetic mutants (Figure 4D). Rescue of the RNAi
phenotype by extra copies of lin-35 was stronger in mir-35-
41(gk262) than in lin-35(n745), possibly due to the reduction versus
complete absence of LIN-35 protein in these mutants, respectively.
To test if extra copies of lin-35 specifically rescues the RNAi
hypersensitivity of mir-35-41(gk262), we introduced the transgene
into other enhanced RNAi mutants. The response to unc-22(RNAi)
was unaffected by the addition of the lin-35(+) transgene to eri-1 or
rrf-3 mutants, supporting the conclusion that the RNAi hypersen-
sitivity of the mir-35-41 mutants can be attributed to reduced lin-
35/Rb. A further prediction of this model is that a mir-35-41;lin-35
double mutant would exhibit the same RNAi response as the lin-35
single mutant. However, the double mutant proved to be inviable
and could not be tested for RNAi sensitivity.
The lin-35/Rb gene is a member of the synthetic multivulva B
(synMuv B) family, which includes transcriptional repressor and
chromatin modifying genes [45]. Worms with combined muta-
tions in synMuv B and synMuv A genes produce multiple vulva
structures because of cell lineage defects [49]. In addition to lin-35,
some of the other synMuv B genes, such as lin-53, lin-9 and dpl-1,
also negatively regulate the exo–RNAi pathway and cause
enhanced RNAi when mutated [22,23]. We tested if the decreased
Table 2. The RNAi sensitivity of mir-35-41(gk262) mutant
worms is dependent on core RNAi factors.
Worm strains Phenotype %
Unaffected Twitching Paralyzed
wild type (629) 10618 8 632 62
rde-1(ne300) (282) 100 0 0
rde-4(ne301) (142) 100 0 0
rrf-1(pk1417) (254) 100 0 0
mir-35-41(gk262) (651) 0 17658 3 614
mir-35-41(gk262);rde-1(ne300) (105) 100 0 0
mir-35-41(gk262);rde-4(ne301) (112) 100 0 0
mir-35-41(gk262);rrf-1(pk1417) (187) 100 0 0
L4 staged worms of each strain were transferred to unc-22 RNAi and the
percentage of unaffected, twitching or paralyzed adult worms was scored
28 hours later. Results are mean 6 standard deviation (average of at least 2
experiments). Numbers in parentheses following the genotype represent the
total number of worms scored.
doi:10.1371/journal.pgen.1002536.t002
Table 3. The RNAi hypersensitivity of mir-35-41(gk262) is
comparable to that of lin-35(n745).
Worm strains Phenotype %
Unaffected Twitching Paralyzed
wild-type (629) 10618 8 632 62
rrf-3(pk1426) (594) 0 83614 1765
eri-1(mg366) (343) 0 73632 7 63
ergo-1(tm1860) (452) 0 66643 4 66
lin-35(n745) (248) 0 5629 5 67
mir-35(gk262) (651) 0 17658 3 614
L4 staged worms of each strain were transferred to unc-22 RNAi and the
percentage of unaffected, twitching or paralyzed adult worms was scored
28 hours later. Results are mean 6 standard deviation (average of at least 2
experiments). Numbers in parentheses represent the total number of worms
scored.
doi:10.1371/journal.pgen.1002536.t003
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multiple vulva (Muv) phenotype when combined with the synMuv
A mutants lin-15a(n767) or lin-8(n111). Double mutants consisting
of mir-35-41(gk262) and either of the synMuv A genes did not
display the Muv phenotype (n=230 adult worms/strain). In
comparison, 100% of the lin-35(n745); lin-15a(n767) and the lin-
35(n745); lin-8(n111) double mutants were Muv (n=240 adult
worms/strain). Taken together, these results suggest that RNAi
efficiency is more sensitive than the vulva formation pathway to
reduction in lin-35/Rb levels or that tissues dependent on lin-35/
Rb for vulva formation produce sufficient protein in the absence of
the miR-35-41 miRNAs.
Maternal rescue of RNAi hypersensitivity in mir-35-41 and
lin-35/Rb mutants
Previous work has shown that the miR-35-41 cluster of miRNAs
is predominantly expressed in embryos with comparatively little
expression in larval and adult somatic tissues [34]. In fact,
miRNAs from this cluster make up about 75% of all mature
miRNAs present in early embryos [50]. Since the miR-35-41
miRNAs are present in one-cell stage embryos before zygotic
transcription by RNA Polymerase II has initiated [50,51], the
miRNAs or their precursors are likely supplied by maternal germ
cells. Thus, we tested if maternal contribution of mir-35-41 activity
would be sufficient to regulate RNAi sensitivity. Since our results
Figure 3. Mis-regulation of the E01G4.5 endo–siRNA target in mir-35-41 mutants. RT-qPCR of E01G4.5 pre-mRNA (A) and mature mRNA (B)
normalized to 18S rRNA and compared to wild type levels (mean 6 s.e.m., n=3, *, P,0.05).
doi:10.1371/journal.pgen.1002536.g003
Figure 2. The RNAi hypersensitivity of mir-35-41 mutants is independent of nrde-3 activity. (A) Fluorescent microscopy showing
subcellular localization of GFP::NRDE-3 in seam cells of the indicated genotypes. Pictures are representative of 50 worms analyzed for each strain.
(B) Histogram representing the percentages of paralyzed worms for the indicated strains fed unc-22 dsRNA for 28 hours from the L4 to adult stage.
The means and standard deviations from three independent experiments are graphed.
doi:10.1371/journal.pgen.1002536.g002
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PLoS Genetics | www.plosgenetics.org 5 March 2012 | Volume 8 | Issue 3 | e1002536Figure 4. Decreased LIN-35/Rb contributes to the RNAi hypersensitivity of mir-35-41(gk262) worms. (A) Northern blot analyses of lin-35/
Rb mRNA levels in WT, mir-35-41(gk262) and lin-35(n745) embryos. After normalization to actin mRNA the average and standard deviation from 3
independent experiments was calculated with wild type levels set to one. (B) LIN-35 protein is decreased in mir-35-41(gk262) embryos compared to
wild type, as shown by western blotting. After normalization to tubulin the average and standard deviation from 4 independent experiments was
calculated with wild type levels set to one (Student’s t-test *p,4610
25). (C) PAGE Northern blot analysis of RNA from wild type and lin-35(n475)
embryos shows similar levels of pre- and mature miR-35 expression. The rRNAs are shown as loading controls. Results are representative of 3
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through lin-35/Rb, we also analyzed maternal rescue of lin-
35(n745). Crossing of mir-35-41(gk262) or lin-35(n745) hermaph-
rodites to wild type males rescued the unc-22(RNAi) paralyzed
phenotype to ,20% in the F1 progeny compared to ,80% in the
parental strains (Figure 5). These heterozygous F1’s were allowed
to self-fertilize and the resulting F2 progeny were scored for the
paralysis phenotype and then genotyped. Regardless of the zygotic
genotype, the worms that had come from mothers with one wild
type allele for mir-35-41 or lin-35 were less sensitive to unc-
22(RNAi) than the original mutant strains (Figure 5). Thus,
maternal contribution of mir-35-41 or lin-35/Rb is sufficient to
regulate RNAi sensitivity.
Discussion
We have shown that the mir-35-41 miRNA gene inhibits the
exogenous RNAi pathway by positively regulating the expression
of LIN-35/Rb protein. The effect of the miR-35-41 miRNAs on
LIN-35/Rb levels is likely indirect as miRNAs typically repress
gene expression and obvious binding sites for the miRNAs are not
present in the lin-35 sequence. Regulation of LIN-35/Rb appears
to be through a post-transcriptional mechanism since mRNA
levels were unaffected in mir-35-41 mutants. We, and others, have
been unable to identify direct targets of mir-35-41 that could
explain the mis-regulation of LIN-35 levels, RNAi hypersensitivity,
or embryonic lethal phenotypes of mir-35-41 mutant strains [32].
Positive regulation of the endo–siRNA pathway by mir-35-41 is
likely indirect through targets of this miRNA family. Although few
predicted targets of miR-35-41 were up-regulated upon loss of
these miRNAs, this result is consistent with a recent study showing
that embryonic targets of miR-35-41 undergo deadenylation while
the rest of the mRNA remains stable in many cases [36]. Thus,
microarrays lack the sensitivity to detect genes mis-regulated in
mir-35-41 mutant embryos. The seven miRNAs in the miR-35-41
cluster share a common seed sequence and may regulate many
genes that affect the viability and RNAi sensitivity phenotypes of
mir-35-41 mutants, which could prevent individual targets from
being discovered through genetic approaches.
The reason for enhanced exo–RNAi in lin-35 mutant strains
is yet to be fully understood. Consistent with its role as a
transcriptional repressor, loss of lin-35/Rb activity results in mis-
expression of germline specific genes in somatic cells [23,24,52].
However, this effect alone cannot explain the enhanced RNAi, as
lin-35 mutants exhibit hypersensitivity in both germline and
somatic cells [22,52]. Several genes for Argonaute proteins that
function in the RNAi pathway are also up-regulated in lin-35/Rb
mutants [24]. Additionally, targets of endo–siRNAs are overex-
pressed in the absence of lin-35/Rb, indicating that the endo–
RNAi pathway is defective in lin-35/Rb mutants [24]. Thus, the
increased expression of RNAi factors and reduced competition
with the endo–RNAi pathway may underlie the improved
efficiency of RNAi in lin-35 mutants. We found that sufficient
endo–siRNAs are produced to target NRDE-3 to the nucleus in
lin-35/Rb and mir-35-41 mutants, suggesting that these genes
regulate the function, but not accumulation, of endo–siRNAs.
Furthermore, both the spliced and unspliced forms of the endo–
siRNA target E01G4.1 were up-regulated in mir-35-41 mutants.
Since RNAi can silence targets at the transcriptional level in
worms, mir-35-41 may also regulate RNAi effectiveness through
this pathway [7,8,53].
RNAi initiated from exogenous dsRNA can propagate across
generations in worms and other organisms [54,55,56,57]. While
the Argonaute RDE-1 and dsRNA binding protein RDE-4 are
required to activate the RNAi response, they are dispensable for
maintenance of RNAi [55,57]. Instead, chromatin remodeling
factors seem to mediate the inheritance of RNAi-induced
phenotypes [53,57]. Thus, the original RNA signal that directs
post-transcriptional silencing of complementary targets may also
stimulate chromatin remodeling events that repress gene expres-
sion across generations. Our results indicate that mir-35-41,
through regulation of lin-35/Rb, decreases exo–RNAi potency
and that this effect can be maternally contributed. The RNAi
hypersensitivity of lin-35/Rb mutants can also be maternally
rescued when the gene is expressed from the chromosomal locus
but not from a transgene (Figure 4D and Figure 5). The inability of
Ex[lin-35(+); sur-5::GFP] transgenes to provide maternal rescue has
previously been observed and is likely due to the generally poor
expression of transgenes in the germline [48,58].
The mir-35-41 miRNAs are expressed in oocytes and present in
early embryos prior to the onset of zygotic transcription [32,50].
This expression pattern is consistent with our demonstration that
maternal contribution is sufficient to regulate exo–RNAi sensitiv-
ity. However, this activity can also be provided by the wave of
zygotic expression of mir-35-41 during embryogenesis [50], since
Figure 5. Maternal rescue of RNAi hypersensitivity in mir-35-41
and lin-35/Rb mutants. Histogram representing the percent of
paralyzed worms for the indicated strains fed unc-22 dsRNA for
28 hours from the L4 to adult stage. Wild type and the mutants mir-35-





to wild type males containing a GFP expressing transgene to generate
green heterozygous F1 progeny (m
2/z
+), which were transferred to unc-
22 RNAi and scored for paralysis. To test for maternal rescue of RNAi
sensitivity, heterozygous F1s were singled and allowed to self fertilize.
The F2 progeny were transferred to unc-22 RNAi and each worm was
scored for paralysis and then genotyped. Error bars represent the
standard error of the mean (s.e.m) for two independent experiments.
doi:10.1371/journal.pgen.1002536.g005
independent experiments. (D) The indicated worm strains were grown on bacteria expressing unc-22 dsRNA. Ex[lin-35; sur-5::GFP] is an
extrachromosomal array that expresses lin-35 in GFP positive (+) worms. Int[sur-5::GFP] is an integrated array that expresses GFP in all worms and
Ex[myo-2::GFP] is an extrachromosomal array that expresses GFP in worms that inherit the array. Phenotype was scored as percent of twitching or
paralyzed worms after 28 h of exposure to RNAi from the L4 to adult stage. Error bars represent the standard error of the mean (s.e.m) for at least two
independent experiments.
doi:10.1371/journal.pgen.1002536.g004
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hypersensitivity phenotype. Although the sequences of the mir-35-
41 miRNAs are not conserved across species, many animals
express high levels of poorly conserved miRNAs from clusters
in embryonic stem cells and during early embryogenesis
[38,59,60,61]. One role for these miRNAs is to target maternal
mRNAs for degradation [36,38,59,62]. Our results show that
miRNAs can also affect the activity of other small RNA pathways,
demonstrating a broad function in regulating gene expression
through both direct and indirect silencing mechanisms.
Materials and Methods
Nematode strains
C. elegans worm strains were maintained on NGM plates seeded
with OP50 bacteria, under standard conditions [63]. Worms were
synchronized by hypochlorite treatment of gravid hermaphrodites
followed by overnight hatching of embryos at 20uC. Strains used
in this study include the following: wild type (WT) Bristol N2
strain, NL2098 rrf-1(pk1417)I, MT10430 lin-35(n745)I, VC514
mir-35-41(gk262)II, NL2099 rrf-3(pk1426)II, MT111 lin-8(n111)II,
WM49 rde-4(ne301)III, GR1373 eri-1(mg366)IV, WM158 ergo-
1(tm1860)V, WM27 rde-1(ne219)V, MT1806 lin-15A(n767)X,
YY158 nrde-3(gg66)X. Double mutants: PQ300 [mir-35-41
(gk262);rde-1(ne219)], PQ301 [mir-35-41(gk262);rde-4(ne301)], PQ
302 [mir-35-41(gk262); eri-1(mg366)], PQ303 [mir-35-41(gk262);rrf-
1(pk1417)], PQ304 [mir-35-41(gk262); ergo-1(tm1860)], PQ421
[mir-35(gk262);lin-8(n111)], PQ422 [mir-35-41(gk262);lin-15A(n
767)], PQ423 [lin-35(n745);lin-8(n111)], PQ424 [lin-35(n745); lin-
15A(n767)], PQ459 [mir-35-41(gk262);nrde-3(gg66)]. Non-integrat-
ed transgenic strains: PQ20 [mir-35-41(gk262); apEX160 [mir-35-
41]], MH1461 [lin-35(n745); kuEx119 [lin-35(+); sur-5::GFP]],
PQ416 [mir-35-41(gk262); kuEx119 [lin-35(+), sur-5::GFP]], PQ
439 [mir-35-41(gk262); Ex [myo-2::GFP)], PQ456 [eri-1(mg366);
kuEx119 [lin-35(+), sur-5::GFP]], PQ458 [rrf-3 (pk1426); kuEx119
[lin-35(+); sur-5::GFP]]. Integrated transgenic strains: YY174
[ggIS1 [nrde-3p::3xflag::gfp::nrde-3]], YY178 eri-1(mg366); [ggIS1
[nrde-3p::3xflag::gfp::nrde-3]], PQ427 [mir-35-41 (gk262); yy1774
[ggIS1 [nrde-3p::3xflag::gfp::nrde-3]], PQ428 [mir-35-41(gk262);nrIs20
[sur-5::nls-gfp]], PD4251 ccIs4251I [myo-3::Ngfp-lacZ].
Worm viability was assayed by synchronizing worms and
plating L1 hatchlings at 20uC. Worms were transferred to
individual plates at the L4 stage and allowed to lay embryos for
24 h at 20uCo r2 5 uC. Parents were then removed from the plates
and embryos were counted. Viable worms were counted 40 hours
later. Percent viable progeny represents the number of viable
worms/total number of embryos laid.
RNAi experiments
RNAi plates were prepared using 25 ug/mL carbenicillin and
6m MI P T G( I s o p r o p y lb-D-1-thiogalactopyranoside, Apex). RNAi
clones were obtained from the Ahringer feeding RNAi library [64].
For most experiments synchronized L1 worms were cultured on
OP50 until the L4 stage (40 hours) and then transferred to RNAi
food. After 28 hours adults were scored for unc-22, lin-1 and sqt-1
phenotypes. For pos-1and sex-1 RNAi, L1 worms were directly plated
on RNAi food and allowed to grow to adults. Parents were then
transferred to individual RNAi plates and allowed to lay about 50
embryos. Percent embryonic lethality was calculated as the number
of embryos that did not hatch by 40 hours later. For paternal/zygotic
rescue experiments, wild-type male worms containing a body muscle
GFP marker (PD4251) were crossed to mir-35(gk262) (mir-352/2)
mutanthermaphrodites.Parentswereremovedfromthematingplate
after 24 hours. Young GFP positive worms represented heterozygous
mir-352/+ F1 cross progeny. F1s were allowed to grow to the L4
stage and 50 GFP positive worms were transferred to unc-22(RNAi).
F1s were scored for phenotypes 28 hours later. For maternal rescue,
GFP positive F1’sweretransferred to individual plates and allowed to
lay self-fertilized F2 embryos. Fifty F2 worms at the L4 stage were
transferred to unc-22(RNAi). Each worm was scored for phenotypes
28 hours later, lysed and genotyped.
RNA and protein analyses
Trizol reagent (Invitrogen) was used to extract total RNA from
frozenembryopelletsofthewild type(N2)andmir-35(gk262)strains.
RNA samples were reverse-transcribed and hybridized to arrays
following the Affymetrix manufacturer’s protocol. Samples from
three independent replicates of each strain were hybridized to the
Affymetrix GeneChip C. elegans Genome Arrays representing
22,500 transcripts. Microarray samples were processed by the
UCSD GeneChip Microarray Core. The raw data was normalized
and t-statics were computed using R and Bioconductor (www.
bioconductor.org) with the ‘‘affy’’ package and Benjamini-Hoch-
berg (BH) correction method for multiple comparisons [65]. RNA
levels that changed at least 1.5-fold with a probability of p,0.005
after BH correction were considered significantly different in mir-
35(gk262)mutants relative to wild-type.Quantitative real-time PCR
of reverse transcribed RNA (RT-qPCR) was performed with DNase
treated RNA and the primers listed in Table S2. Northern blots to
detect mRNAs and miRNAs and Western blots to detect proteins
wereperformed aspreviouslydescribed[66].TheantibodyforLIN-
35 was provided by the Horvitz lab [45].
Supporting Information
Figure S1 Temperature sensitive embryonic lethality of mir-35-
41(gk262) mutants. Percent viable progeny of N2 (wild type) and
mir-35-41(gk262) at 20uC and 25uC, representing the average
number of embryos laid that reached the L4 stage, per parent.
Error bars for graphs represent the standard deviation for three
independent experiments (n.200 embryos for each condition).
(TIF)
Table S1 Microarray data. (a) Up-regulated genes in mir-35-41
mutant embryos. Affymetrix probes and corresponding expression
changes in mir-35-41(gk262) compared to wild type embryos. Gene
IDs in column ‘‘I’’ represent the overlap with endo–siRNA targets
listed on Sheet 2. Zeros represent non-overlap. (b) Down-regulated
genes in mir-35-41 mutant embryos. Affymetrix probes and
corresponding expression changes in mir-35-41(gk262) compared
to wild type embryos. Gene IDs in column ‘‘I’’ represent the
overlap with endo–siRNA targets listed on Sheet 2. Zeros
represent non-overlap. (c) Compiled endo–siRNA targets from
Lee et al. [18], Ruby et al. [11], Pak et al. [13], Gu et al. [47].
(XLS)
Table S2 List of Primers. Primers used for generation of the mir-
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